Faculty of Hepato-Biliary-Pancreatic Surgery, Chinese People's Liberation Army (PLA) General Hospital, Institute of Hepatobiliary Surgery of Chinese PLA, Key Laboratory of Digital Hepatobiliary Surgery, PLA, Beijing.
Department of Liver Transplantation and Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan.
Int J Surg. 2023 Apr 1;109(4):679-688. doi: 10.1097/JS9.0000000000000204.
Microvascular invasion (MVI) is a risk factor for postoperative survival outcomes for patients with hepatocellular carcinoma (HCC) after hepatectomy. This study aimed to evaluate the impact of anatomical resection (AR) versus nonanatomical resection (NAR) combined with resection margin (RM) (narrow RM <1 cm vs. wide RM ≥1 cm) on long-term prognosis in hepatitis B virus-related HCC patients with MVI.
Data from multicenters on HCC patients with MVI who underwent hepatectomy was analyzed retrospectively. Propensity score matching analysis was performed in these patients.
The 1965 enrolled patients were divided into four groups: AR with wide RM ( n =715), AR with narrow RM ( n =387), NAR with wide RM ( n =568), and NAR with narrow RM ( n =295). Narrow RM ( P <0.001) and NAR ( P <0.001) were independent risk factors for both overall survival and recurrence-free survival in these patients based on multivariate analyses. For patients in both the AR and NAR groups, wide RM resulted in significantly lower operative margin recurrence rates than those patients in the narrow RM groups after propensity score matching ( P =0.002 and 0.001). Patients in the AR with wide RM group had significantly the best median overall survival (78.9 vs. 51.5 vs. 48.0 vs. 36.7 months, P <0.001) and recurrence-free survival (23.6 vs. 14.8 vs. 17.8 vs. 9.0 months, P <0.001) than those in the AR with narrow RM, NAR with wide RM or with narrow RM groups, respectively.
If technically feasible and safe, AR combined with wide RM should be the recommended therapeutic strategy for HCC patients who are estimated preoperatively with a high risk of MVI.
微血管侵犯(MVI)是肝癌(HCC)患者肝切除术后生存结局的危险因素。本研究旨在评估解剖性切除术(AR)与非解剖性切除术(NAR)联合切缘(RM)(窄 RM <1cm 与宽 RM ≥1cm)对乙型肝炎病毒相关 HCC 伴 MVI 患者长期预后的影响。
回顾性分析多中心 HCC 伴 MVI 患者接受肝切除术的数据。对这些患者进行倾向评分匹配分析。
1965 例患者被分为四组:宽 RM 的 AR(n=715)、窄 RM 的 AR(n=387)、宽 RM 的 NAR(n=568)和窄 RM 的 NAR(n=295)。多变量分析显示,窄 RM(P<0.001)和 NAR(P<0.001)是这些患者总生存和无复发生存的独立危险因素。对于 AR 和 NAR 两组患者,在倾向评分匹配后,宽 RM 组的手术切缘复发率明显低于窄 RM 组(P=0.002 和 0.001)。在 AR 组中,宽 RM 组的中位总生存时间(78.9 个月比 51.5 个月比 48.0 个月比 36.7 个月,P<0.001)和无复发生存时间(23.6 个月比 14.8 个月比 17.8 个月比 9.0 个月,P<0.001)均明显优于窄 RM 组、宽 RM 的 NAR 组和窄 RM 的 NAR 组。
如果在技术上可行且安全,对于术前估计有较高 MVI 风险的 HCC 患者,应推荐 AR 联合宽 RM 作为治疗策略。